Skip to main content
Log in

Androgen receptor expression in primary prostate cancers of lobund-wistar rats and in tumor-derived cell lines

  • Growth, Differentiation, And Senescence
  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Summary

Prostate tumors were induced in Lobund-Wistar rats by treatment with N-methyl-N-nitrosourea (MNU) and testosterone propionate (TP). Androgen receptor (AR) expression was confirmed in 16 (100%) of the primary prostate cancers, with strong uniform staining in well-differentiated tumors and more variable AR immunoreactivity in poorly differentiated tumors. Epithelial cell lines were established from nine of the tumors. At early passages, four of the tumor cell lines tested were strongly immunoreactive for AR; however, only two of the cell lines, E2(A) and F2, have remained AR-positive. These cell lines specifically bind 3H-DHT at 40 and 19 fmol/mg protein, respectively, and express a 110 kDa AR immunoreactive protein. Proliferation in in vitro culture of both E2(A) and F2 cells was increased in the presence of 5α-dihydrotestosterone (DHT). The antiandrogen, hydroxyflutamide was able to prevent the DHT-induced growth of E2(A) but not F2 cells. Furthermore, hydroxyflutamide alone increased proliferation of F2 cells, suggesting that the androgen signalling pathway in this cell line may be abnormal. Tumorigenicity of the AR-expressing and nonexpressing cell lines was confirmed by xenograft formation following subcutaneous inoculation into intact male nude mice. In summary, carcinogen-induced prostate tumors of Lobund-Wistar rats express AR and two of nine cell lines derived from the tumors express AR. Further evaluation of AR structure in primary prostate tumors forming spontaneously or following MNU and TP induction will determine whether, as in human prostate cancers, disease progression in Lobund-Wistar rats is associated with mutations in the AR gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bentel, J. M.; Tilley, W. D. Androgen receptors in prostate cancer. J. Endocrinol. 151:1–11; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Bosland, M. C. Chemical and hormonal induction of prostate cancer in animal models. Urol. Oncol. 2:103–110; 1996.

    Google Scholar 

  • Chang, C. F.; Pollard, M. In vitro propagation of prostate adenocarcinoma cells from rats. Invest. Urol. 14:331–334; 1977.

    PubMed  CAS  Google Scholar 

  • Chirgwin, J. M.; Przybyla, A. E.; MacDonald, R. J.; Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:4294–4299; 1979.

    Article  Google Scholar 

  • Clements, J. A.; Matheson, B. A.; Wines, D. R.; Brady, J. M.; MacDonald, R. J.; Funder, J. W. Androgen dependence of specific kallikrein gene family members expressed in rat prostate. J. Biol. Chem. 263:16132–16137; 1988.

    PubMed  CAS  Google Scholar 

  • Clements, J. A.; Mukhtar, A.; Holland, A. M.; Ehrlich, A. R.; Fuller, P. J. Kallikrein gene family expression in the rat ovary: localization to the granulosa cell. Endocrinology 136:1137–1144; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, M. B.; Heidger, P. M.; Lubaroff, D. M. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats. Cancer Res. 54:626–628; 1994.

    PubMed  CAS  Google Scholar 

  • Culig, Z.; Hobisch, A.; Hittmair, A.; Peterziel, H.; Cato, A. C. B.; Bartsch, G.; Klocker, H. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 35:63–70; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Danielpour, D.; Kadomatsu, K.; Anzano, M. A.; Smith, J. M.; Sporn, M. B. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res. 54:3413–3421; 1994.

    PubMed  CAS  Google Scholar 

  • Dong, J.-T.; Lamb, P. W.; Rinker-Schaeffer, C. W.; Vukanovic, J.; Ichikawa, T.; Isaacs, J. T.; Barrett, J. C. KAll, a metastasis suppressor gene for prostatic cancer on human chromosome 11p11.2. Science (Wash DC) 268:884–886; 1995.

    Article  CAS  Google Scholar 

  • Foster, B. A.; Gingrich, J. R.; Kwon, E. D.; Madias, C.; Greenberg, N. M. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res. 57:3325–3330; 1997.

    PubMed  CAS  Google Scholar 

  • Frydenberg, M.; Stricker, P. D.; Kaye, K. W. Prostate cancer diagnosis and management. Lancet 349:1681–1687; 1997.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg, N. M.; DeMayo, F.; Finegold, M. J.; Medina, D.; Tilley, W. D.; Aspinall, J. O.; Cunha, G. R.; Donjacour, A. A.; Matusik, R. J.; Rosen, J. M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 92:3439–3443; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Hobisch, A.; Culig, Z.; Radmayr, C.; Bartsch, G.; Klocker, H.; Hittmair, A. Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res. 55:3068–3072; 1995.

    PubMed  CAS  Google Scholar 

  • Hoover, D. M.; Best, K. L.; McKenney, B. K.; Tamura, R. N.; Neubauer, B. L. Experimental induction of neoplasia in the accessory sex organs of male Lobund-Wistar rats. Cancer Res. 50:142–146; 1990.

    PubMed  CAS  Google Scholar 

  • Husmann, D. A.; Wilson, C. M.; McPhaul, M. J.; Tilley, W. D.; Wilson, J. D. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 126:2359–2368; 1990.

    Article  PubMed  CAS  Google Scholar 

  • Isaacs, J. T.; Isaacs, W. B.; Feitz, W. F. J.; Scheres, J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9:261–281; 1986.

    Article  PubMed  CAS  Google Scholar 

  • Isaacs, J. T. The R-3327 system of rat prostatic cancers. Urol. Oncol. 2:115–116; 1996.

    Google Scholar 

  • Leav, I.; Kwan, P. W. L.; Merk, F. B.; Chang, C.; Ho, S.-M. Immunohistochemical and in situ hybridization studies of androgen receptor expression in a transplantable androgen independent prostatic carcinoma line (AIT) of Noble rats. Lab. Invest. 67:788–795; 1992.

    PubMed  CAS  Google Scholar 

  • Lee, C.; Sutkowski, D. M.; Sensibar, J. A.; Zelner, D.; Kim, I.; Amsel, I.; Shaw, N.; Prins, G. S.; Kozlowski, J. M. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 136:796–803; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Lucia, M. S.; Anzano, M. A.; Slayter, M. V.; Anver, M. R.; Green, D. M.; Schrader, M. W.; Logsdon, D. L.; Driver, C. L.; Brown, C. C.; Peer, C. W.; Roberts, A. B.; Sporn, M. B. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)-retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. Cancer Res. 55:5621–5627; 1995.

    PubMed  CAS  Google Scholar 

  • MacDonald, R. J.; Southard-Smith, E. M.; Kroon, E. Disparate tissue-specific expression of members of the tissue kallikrein multigene family of the rat. J. Biol. Chem. 271:13684–13690; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Neubauer, B. L.; Best, K. L.; Goode, R. L.; Heiman, M. L.; Hoover, D. M.; Robertson, D. W.; Sarosdy, M. F.; Shaar, C. J.; Tanzer, L. R.; Merriman, R. L. Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma. Cancer Res. 52:4663–4671; 1992.

    PubMed  CAS  Google Scholar 

  • Oh, W. K.; Kantoff, P. W. Management of hormone refractory prostate cancer—current standards and future prospects. J. Urol. 160:1220–1229; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Parker, S. L.; Tong, T.; Bolden, S.; Wingo, P. A. Cancer statistics, 1997. CA Cancer J. Clin. 47:5–27; 1997.

    PubMed  CAS  Google Scholar 

  • Pollard, M. Spontaneous prostate adenocarcinomas in aged germfree Wistar rats. J. Natl. Cancer Inst. 51:1235–1241; 1973.

    PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H. Transplantable metastasizing adenocarcinomas in rats. J. Natl. Cancer Inst. 54:643–649; 1975.

    PubMed  CAS  Google Scholar 

  • Pollard, M.; Chang, C. F.; Luckert, P. H. Investigations on prostate adenocarcinomas in rats. Oncology 34:129–132; 1977.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone. J. Natl. Cancer Inst. 77:583–587; 1986.

    PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H.; Snyder, D. L. Prevention of prostate cancer and liver tumours in L-W rats by moderate dietary restriction. Cancer 64:686–690; 1989a.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H.; Snyder, D. L. Prevention and treatment of experimental prostate cancer in Lobund-Wistar rats. 1. Effects of estradiol, dihydrotestosterone, and castration. Prostate 15:95–103; 1989b.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H.; Snyder, D. L. The promotional effect of testosterone on induction of prostate cancer in MNU-sensitized L-W rats. Cancer Lett. 45:209–212; 1989c.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H.; Sporn, M. B. Prevention of primary prostate cancer in Lobund-Wistar rats by 4-hydroxyphenylretinamide. Cancer Res. 51:3610–3616; 1991.

    PubMed  CAS  Google Scholar 

  • Pollard, M.; Luckert, P. H. Early manifestations of induced prostate tumors in Lobund-Wistar rats. Cancer Lett. 67:113–116; 1992.

    Article  PubMed  CAS  Google Scholar 

  • Pollard, M. Lobund-Wistar rat model of prostate cancer in man. Prostate 37:1–4; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Ricciardelli, C.; Horsfall, D. J.; Skinner, J. M.; Henderson, D. W.; Marshall, V. R.; Tilley, W. D. Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate. In Vitro Cell. Dev. Biol. 25:1016–1024; 1989.

    Article  PubMed  CAS  Google Scholar 

  • Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Press; 1989:9.31–39.57.

    Google Scholar 

  • Shain, S. A.; McCullough, B.; Segaloff, A. Spontaneous adenocarcinomas of the ventral prostate of aged AXC rats. J. Natl. Cancer Inst. 55:177–180; 1975.

    PubMed  CAS  Google Scholar 

  • Shain, S. A.; Huot, R. I.; Gorelic, L. S.; Smith, G. C. Biochemical and morphological characterization of clonal AXC rat prostate cancer cells. Cancer Res. 44:2033–2042; 1984.

    PubMed  CAS  Google Scholar 

  • Slayter, M. V.; Anzano, M. A.; Kadomatsu, K.; Smith, J. M.; Sporn, M. B. Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading. Cancer Res. 54:1440–1445; 1994.

    PubMed  CAS  Google Scholar 

  • Tamano, S.; Rehm, S.; Waalkes, M. P.; Ward, J. M. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using n-nitrosomethylurea and testosterone. Vet. Pathol. 33:557–567; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Thompson, T. C.; Southgate, J.; Kitchner, G.; Land, H. Multi-stage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56:917–930; 1989.

    Article  PubMed  CAS  Google Scholar 

  • Tilley, W. D.; Marcelli, M.; Wilson, J. D.; McPhaul, M. J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA 86:327–331; 1989.

    Article  PubMed  CAS  Google Scholar 

  • Tilley, W. D.; Wilson, C. M.; Marcelli, M.; McPhaul, M. J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50:5382–5386; 1990.

    PubMed  CAS  Google Scholar 

  • Tilley, W. D.; Lim-Tio, S. S.; Horsfall, D. J.; Aspinall, J. O.; Marshall, V. R.; Skinner, J. M. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res. 54:4096–4102; 1994.

    PubMed  CAS  Google Scholar 

  • van Kuppeveld, F. J. M.; van der Logt, J. T. M.; Angulo, A. F.; van Zoest, M. J.; Quint, W. G. V.; Niesters, H. G. M.; Galama, J. M. D.; Melchers, W. J. G. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl. Environ. Microbiol. 58:2606–2615; 1992.

    PubMed  Google Scholar 

  • Veldscholte, J. C. R.; Kuiper, G. G.; Jenster, G.; Berrevoets, C.; Claasen, E.; vanRooij, H. C.; Trapman, J.; Brinkmann, A. O.; Mulder, E. A. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun. 173:534–540; 1990.

    Article  PubMed  CAS  Google Scholar 

  • Verity, K.; Fuller, P. J. Isolation of a rat amiloride-binding protein cDNA clone: tissue distribution and regulation of expression. Am. J. Physiol. 266:C1505-C1512; 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bentel, J.M., Pickering, M.A., Pollard, M. et al. Androgen receptor expression in primary prostate cancers of lobund-wistar rats and in tumor-derived cell lines. In Vitro Cell.Dev.Biol.-Animal 35, 655–662 (1999). https://doi.org/10.1007/s11626-999-0106-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11626-999-0106-5

Key words

Navigation